世界のレムデシビル（新型コロナウイルス感染症）市場予測（～2028年）：5mg、10mg、50mg、100mg

• 英文タイトル：Global Remdesivir (COVID-19) Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

• レポートコード：GIR-22E8953 • 出版社/出版日：GlobalInfoResearch / 2022年5月 • レポート形態：英文、PDF、92ページ • 納品方法：Eメール（2~3営業日） • 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥522,000 (USD3,480)	▷ お問い合わせ
Multi User	￥783,000 (USD5,220)	▷ お問い合わせ
Corporate User	￥1,044,000 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

レムデシビル（新型コロナウイルス感染症）市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。 GlobalInfoResearchの最新の調査によると、世界のレムデシビル（新型コロナウイルス感染症）の市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。 レムデシビル（新型コロナウイルス感染症）市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。 種類別セグメントは次をカバーします。 ・5mg、10mg、50mg、100mg 用途別セグメントは次のように区分されます。 ・病院、クリニック、薬局、その他 世界のレムデシビル（新型コロナウイルス感染症）市場の主要な市場プレーヤーは以下のとおりです。 ・Gilead Sciences、Bright Gene、Hainan Haiyao、Kelun Pharma、Hunan Warrant Pharmaceutical、Borui Bio-Pharmaceutical、Berry Global Group、Inovio Pharmaceuticals 地域別セグメントは次の地域・国をカバーします。 ・北米（米国、カナダ、メキシコ） ・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア） ・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア） ・南アメリカ（ブラジル、アルゼンチン、コロンビア） ・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ） 本調査レポートの内容は計15章あります。 ・第1章では、レムデシビル（新型コロナウイルス感染症）製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。 ・第2章では、主要なレムデシビル（新型コロナウイルス感染症）メーカーの企業概要、2019年～2022年までのレムデシビル（新型コロナウイルス感染症）の価格、販売量、売上、市場シェアを掲載しています。 ・第3章では、主要なレムデシビル（新型コロナウイルス感染症）メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。 ・第4章では、2017年～2028年までの地域別レムデシビル（新型コロナウイルス感染症）の販売量、売上、成長性を示しています。 ・第5、6章では、2017年～2028年までのレムデシビル（新型コロナウイルス感染症）の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。 ・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域でのレムデシビル（新型コロナウイルス感染症）市場予測を収録しています。 ・第12章では、主要な原材料、主要なサプライヤー、およびレムデシビル（新型コロナウイルス感染症）の産業チェーンを掲載しています。 ・第13、14、15章では、レムデシビル（新型コロナウイルス感染症）の販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。 ***** 目次(一部) ***** ・市場概要 ・メーカー情報（企業概要、製品概要、販売量、価格、売上）：Gilead Sciences、Bright Gene、Hainan Haiyao、Kelun Pharma、Hunan Warrant Pharmaceutical、Borui Bio-Pharmaceutical、Berry Global Group、Inovio Pharmaceuticals ・メーカー別市場シェア ・地域別市場分析2017年-2028年 ・種類別分析2017年-2028年：5mg、10mg、50mg、100mg ・用途別分析2017年-2028年：病院、クリニック、薬局、その他 ・レムデシビル（新型コロナウイルス感染症）の北米市場規模2017年-2028年：アメリカ、カナダ、メキシコ ・レムデシビル（新型コロナウイルス感染症）のヨーロッパ市場規模2017年-2028年：ドイツ、イギリス、フランス、ロシア、イタリア ・レムデシビル（新型コロナウイルス感染症）のアジア市場規模2017年-2028年：中国、日本、韓国、インド、東南アジア、オーストラリア ・レムデシビル（新型コロナウイルス感染症）の南米市場規模2017年-2028年：ブラジル、アルゼンチン ・レムデシビル（新型コロナウイルス感染症）の中東・アフリカ市場規模2017年-2028年：サウジアラビア、トルコ、エジプト、南アフリカ ・原材料および産業チェーン ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論

The Remdesivir (COVID-19) market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Remdesivir (COVID-19) market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Hospital accounting for % of the Remdesivir (COVID-19) global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While 5mg segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Remdesivir (COVID-19) include Gilead Sciences, Bright Gene, Hainan Haiyao, Kelun Pharma, and Hunan Warrant Pharmaceutical, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Remdesivir (COVID-19) market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
5mg
10mg
50mg
100mg
Market segment by Application can be divided into
Hospital
Clinics
Drug Store
Others
The key market players for global Remdesivir (COVID-19) market are listed below:
Gilead Sciences
Bright Gene
Hainan Haiyao
Kelun Pharma
Hunan Warrant Pharmaceutical
Borui Bio-Pharmaceutical
Berry Global Group
Inovio Pharmaceuticals
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Remdesivir (COVID-19) product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Remdesivir (COVID-19), with price, sales, revenue and global market share of Remdesivir (COVID-19) from 2019 to 2022.
Chapter 3, the Remdesivir (COVID-19) competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Remdesivir (COVID-19) breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Remdesivir (COVID-19) market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Remdesivir (COVID-19).
Chapter 13, 14, and 15, to describe Remdesivir (COVID-19) sales channel, distributors, customers, research findings and conclusion, appendix and data source.

レポート目次

---

1 Market Overview
1.1 Remdesivir (COVID-19) Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Remdesivir (COVID-19) Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 5mg
1.2.3 10mg
1.2.4 50mg
1.2.5 100mg
1.3 Market Analysis by Application
1.3.1 Overview: Global Remdesivir (COVID-19) Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Hospital
1.3.3 Clinics
1.3.4 Drug Store
1.3.5 Others
1.4 Global Remdesivir (COVID-19) Market Size & Forecast
1.4.1 Global Remdesivir (COVID-19) Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Remdesivir (COVID-19) Sales in Volume (2017-2028)
1.4.3 Global Remdesivir (COVID-19) Price (2017-2028)
1.5 Global Remdesivir (COVID-19) Production Capacity Analysis
1.5.1 Global Remdesivir (COVID-19) Total Production Capacity (2017-2028)
1.5.2 Global Remdesivir (COVID-19) Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Remdesivir (COVID-19) Market Drivers
1.6.2 Remdesivir (COVID-19) Market Restraints
1.6.3 Remdesivir (COVID-19) Trends Analysis
2 Manufacturers Profiles
2.1 Gilead Sciences
2.1.1 Gilead Sciences Details
2.1.2 Gilead Sciences Major Business
2.1.3 Gilead Sciences Remdesivir (COVID-19) Product and Services
2.1.4 Gilead Sciences Remdesivir (COVID-19) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Bright Gene
2.2.1 Bright Gene Details
2.2.2 Bright Gene Major Business
2.2.3 Bright Gene Remdesivir (COVID-19) Product and Services
2.2.4 Bright Gene Remdesivir (COVID-19) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Hainan Haiyao
2.3.1 Hainan Haiyao Details
2.3.2 Hainan Haiyao Major Business
2.3.3 Hainan Haiyao Remdesivir (COVID-19) Product and Services
2.3.4 Hainan Haiyao Remdesivir (COVID-19) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Kelun Pharma
2.4.1 Kelun Pharma Details
2.4.2 Kelun Pharma Major Business
2.4.3 Kelun Pharma Remdesivir (COVID-19) Product and Services
2.4.4 Kelun Pharma Remdesivir (COVID-19) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Hunan Warrant Pharmaceutical
2.5.1 Hunan Warrant Pharmaceutical Details
2.5.2 Hunan Warrant Pharmaceutical Major Business
2.5.3 Hunan Warrant Pharmaceutical Remdesivir (COVID-19) Product and Services
2.5.4 Hunan Warrant Pharmaceutical Remdesivir (COVID-19) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Borui Bio-Pharmaceutical
2.6.1 Borui Bio-Pharmaceutical Details
2.6.2 Borui Bio-Pharmaceutical Major Business
2.6.3 Borui Bio-Pharmaceutical Remdesivir (COVID-19) Product and Services
2.6.4 Borui Bio-Pharmaceutical Remdesivir (COVID-19) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Berry Global Group
2.7.1 Berry Global Group Details
2.7.2 Berry Global Group Major Business
2.7.3 Berry Global Group Remdesivir (COVID-19) Product and Services
2.7.4 Berry Global Group Remdesivir (COVID-19) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Inovio Pharmaceuticals
2.8.1 Inovio Pharmaceuticals Details
2.8.2 Inovio Pharmaceuticals Major Business
2.8.3 Inovio Pharmaceuticals Remdesivir (COVID-19) Product and Services
2.8.4 Inovio Pharmaceuticals Remdesivir (COVID-19) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Remdesivir (COVID-19) Breakdown Data by Manufacturer
3.1 Global Remdesivir (COVID-19) Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Remdesivir (COVID-19) Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Remdesivir (COVID-19)
3.4 Market Concentration Rate
3.4.1 Top 3 Remdesivir (COVID-19) Manufacturer Market Share in 2021
3.4.2 Top 6 Remdesivir (COVID-19) Manufacturer Market Share in 2021
3.5 Global Remdesivir (COVID-19) Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Remdesivir (COVID-19) Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Remdesivir (COVID-19) Market Size by Region
4.1.1 Global Remdesivir (COVID-19) Sales in Volume by Region (2017-2028)
4.1.2 Global Remdesivir (COVID-19) Revenue by Region (2017-2028)
4.2 North America Remdesivir (COVID-19) Revenue (2017-2028)
4.3 Europe Remdesivir (COVID-19) Revenue (2017-2028)
4.4 Asia-Pacific Remdesivir (COVID-19) Revenue (2017-2028)
4.5 South America Remdesivir (COVID-19) Revenue (2017-2028)
4.6 Middle East and Africa Remdesivir (COVID-19) Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Remdesivir (COVID-19) Sales in Volume by Type (2017-2028)
5.2 Global Remdesivir (COVID-19) Revenue by Type (2017-2028)
5.3 Global Remdesivir (COVID-19) Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Remdesivir (COVID-19) Sales in Volume by Application (2017-2028)
6.2 Global Remdesivir (COVID-19) Revenue by Application (2017-2028)
6.3 Global Remdesivir (COVID-19) Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Remdesivir (COVID-19) Sales by Type (2017-2028)
7.2 North America Remdesivir (COVID-19) Sales by Application (2017-2028)
7.3 North America Remdesivir (COVID-19) Market Size by Country
7.3.1 North America Remdesivir (COVID-19) Sales in Volume by Country (2017-2028)
7.3.2 North America Remdesivir (COVID-19) Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Remdesivir (COVID-19) Sales by Type (2017-2028)
8.2 Europe Remdesivir (COVID-19) Sales by Application (2017-2028)
8.3 Europe Remdesivir (COVID-19) Market Size by Country
8.3.1 Europe Remdesivir (COVID-19) Sales in Volume by Country (2017-2028)
8.3.2 Europe Remdesivir (COVID-19) Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Remdesivir (COVID-19) Sales by Type (2017-2028)
9.2 Asia-Pacific Remdesivir (COVID-19) Sales by Application (2017-2028)
9.3 Asia-Pacific Remdesivir (COVID-19) Market Size by Region
9.3.1 Asia-Pacific Remdesivir (COVID-19) Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Remdesivir (COVID-19) Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Remdesivir (COVID-19) Sales by Type (2017-2028)
10.2 South America Remdesivir (COVID-19) Sales by Application (2017-2028)
10.3 South America Remdesivir (COVID-19) Market Size by Country
10.3.1 South America Remdesivir (COVID-19) Sales in Volume by Country (2017-2028)
10.3.2 South America Remdesivir (COVID-19) Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Remdesivir (COVID-19) Sales by Type (2017-2028)
11.2 Middle East & Africa Remdesivir (COVID-19) Sales by Application (2017-2028)
11.3 Middle East & Africa Remdesivir (COVID-19) Market Size by Country
11.3.1 Middle East & Africa Remdesivir (COVID-19) Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Remdesivir (COVID-19) Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Remdesivir (COVID-19) and Key Manufacturers
12.2 Manufacturing Costs Percentage of Remdesivir (COVID-19)
12.3 Remdesivir (COVID-19) Production Process
12.4 Remdesivir (COVID-19) Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Remdesivir (COVID-19) Typical Distributors
13.3 Remdesivir (COVID-19) Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

---